Pharmacists Weigh Promise and Challenges of Finerenone for Patients With HFpEF
Pharmacy Times
JULY 24, 2025
Yet, despite growing awareness, HFpEF remains difficult to manage due to nonspecific symptoms, limited clinical trial data, and inconsistencies in diagnosis. Kaitlyn Pinkos, PharmD, BCCP, a clinical pharmacy specialist at NewYork-Presbyterian Hospital, shared that even in a dedicated HFpEF clinic, MRA use rates hover around 30% to 50%.
Let's personalize your content